Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

DuPont presents 4-aminoquinazoline cyclin-dependent kinase inhibitors

March 24, 1999

High-affinity RARalpha receptor agonists reported by Eisai at ACS meeting

March 24, 1999

NCI scientists evaluate MMP inhibitor from CollaGenex

March 23, 1999

ACS highlights: design of new antitumor agents based on computer models of tubulin structure

March 23, 1999

New thioureas: synthesis and apoptosis induction

March 23, 1999

SBIR grant to be used by Aurora to identify gene targets, lead compounds relevant to breast cancer

March 23, 1999

Novel acridine-based antitumor agents developed at Italian university

March 23, 1999

Scotia's photodynamic cancer drug receives fast track status from FDA

March 22, 1999

ACS highlights: Agouron and Roche present MMP inhibitor clinical candidate

March 22, 1999

Hungarian research team describes GnRH receptor-targeted antitumor drug conjugates

March 22, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 5, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...